Table 1.
HLA types of the used cell lines and PBMC donors
| Cells | Cell type | HLA-A | HLA-B | HLA-Cw | HLA-DRB1 | HLA-DQB1 |
|---|---|---|---|---|---|---|
| L-428 | HL | 03 | 35 | 04 | 12 | 03 |
| L-540 | HL | 03, 11 | 51 | 02, 15 | 04, 11 | 03 |
| L-1236 | HL | 02 | 51 | 02 | 14 | 05 |
| KM-H2 | HL | 11, 24 | 15, 52 | 04, 12 | 04, 11 | 03 |
| HDLM-2 | HL | 01, 02 | 08, 44 | 05, 07 | 13, 15 | 06 |
| TE-671 | RMS | 01 | 37 | 06 | 03 | 02 |
| A673 | EFT | 01, 02 | 07 | 07 | 04, 15 | 03, 06 |
| SK-N-MC | EFT | 01, 25 | 08 | 07 | 03, 15 | 02, 06 |
| Donor 1 | PBMC | 02, 24 | 15 | 03, 07 | 04, 11 | 03 |
| Donor 7 | PBMC | 01, 02 | 08, 15 | 04, 07 | 01, 11 | 03, 05 |
| Donor 8 | PBMC | 01, 03 | 08, 35 | 04, 07 | 03, 11 | 03 |
Presented are HLA types of the tumor cell lines used in this study (HL Hodgkin’s lymphoma cell lines, RMS cell line from rhabdomyosarcoma, EFT Ewing family tumor cell lines). In addition, HLA types from three PBMC donors are presented